Advertisement
Screener

Merck & Co., Inc. (MRK) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

2.2 / 5 stars · 50/112 Roast Me

Merck & Co., Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Merck & Co., Inc. (MRK) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 0 shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07

  • Merck & Co., Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
  • Merck & Co., Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
  • Merck & Co., Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 15.00M shares, a 114.29% increase year-over-year.
  • Merck & Co., Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 19.00M shares, a 171.43% increase year-over-year.
  • Merck & Co., Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 11.00M shares, a 83.33% increase from fiscal 2024.
  • Merck & Co., Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 6.00M shares, a 20.00% increase from fiscal 2023.
  • Merck & Co., Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 5.00M shares, a 150.00% increase from fiscal 2022.
  • Merck & Co., Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 2.00M shares, a 77.78% decline from fiscal 2021.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month
2026-06-300.00 shares
10-Q · filed 2026-08-07
0.00 shares
10-Q · filed 2026-08-07
2026-03-310.00 shares
10-Q · filed 2026-05-04
2025-12-3111.00M shares
10-K · filed 2026-02-24
2025-09-3015.00M shares
10-Q · filed 2025-11-05
12.00M shares
10-Q · filed 2025-11-05
2025-06-3019.00M shares
10-Q · filed 2026-08-07
12.00M shares
10-Q · filed 2026-08-07
2025-03-3110.00M shares
10-Q · filed 2026-05-04
2024-12-316.00M shares
10-K · filed 2026-02-24
2024-09-307.00M shares
10-Q · filed 2025-11-05
6.00M shares
10-Q · filed 2025-11-05
2024-06-307.00M shares
10-Q · filed 2025-08-05
5.00M shares
10-Q · filed 2025-08-05
2024-03-313.00M shares
10-Q · filed 2025-05-02
2023-12-315.00M shares
10-K · filed 2026-02-24
2023-09-306.00M shares
10-Q · filed 2024-11-06
5.00M shares
10-Q · filed 2024-11-06
2023-06-300.00 shares
10-Q · filed 2024-08-05
0.00 shares
10-Q · filed 2024-08-05
2023-03-311.00M shares
10-Q · filed 2024-05-03
2022-12-312.00M shares
10-K · filed 2025-02-25
2022-09-302.00M shares
10-Q · filed 2023-11-03
5.00M shares
10-Q · filed 2023-11-03
2022-06-302.00M shares
10-Q · filed 2023-08-07
6.00M shares
10-Q · filed 2023-08-07
2022-03-317.00M shares
10-Q · filed 2023-05-05
2021-12-319.00M shares
10-K · filed 2024-02-26
2021-09-308.00M shares
10-Q · filed 2022-11-03
10.00M shares
10-Q · filed 2022-11-03
2021-06-3012.00M shares
10-Q · filed 2022-08-05
11.00M shares
10-Q · filed 2022-08-05
2021-03-3114.00M shares
10-Q · filed 2022-05-05
2020-12-315.00M shares
10-K · filed 2023-02-24
2020-09-305.00M shares
10-Q · filed 2021-11-05
5.00M shares
10-Q · filed 2021-11-05
2020-06-308.00M shares
10-Q · filed 2021-08-09
4.00M shares
10-Q · filed 2021-08-09
2020-03-312.00M shares
10-Q · filed 2021-05-05
2019-12-312.00M shares
10-K · filed 2022-02-25
2019-09-303.00M shares
10-Q · filed 2020-11-05
2.00M shares
10-Q · filed 2020-11-05
2019-06-303.00M shares
10-Q · filed 2020-08-05
4.00M shares
10-Q · filed 2020-08-05
2019-03-312.00M shares
10-Q · filed 2020-05-06
2018-12-316.00M shares
10-K · filed 2021-02-25
2018-09-302.00M shares
10-Q · filed 2019-11-05
7.00M shares
10-Q · filed 2019-11-05
2018-06-3013.00M shares
10-Q · filed 2019-08-06
15.00M shares
10-Q · filed 2019-08-06
2018-03-3114.00M shares
10-Q · filed 2019-05-08
2017-12-315.00M shares
10-K · filed 2020-02-26
2017-09-304.00M shares
10-Q · filed 2018-11-06
2017-06-305.00M shares
10-Q · filed 2018-08-07
4.00M shares
10-Q · filed 2018-08-07
2017-03-312.00M shares
10-Q · filed 2018-05-08
2016-12-3113.00M shares
10-K · filed 2019-02-27
2016-09-304.00M shares
10-Q · filed 2017-11-07
13.00M shares
10-Q · filed 2017-11-07
2016-06-3013.00M shares
10-Q · filed 2017-08-08
12.00M shares
10-Q · filed 2017-08-08
2016-03-3110.00M shares
10-Q · filed 2017-05-09
2015-12-319.00M shares
10-K · filed 2018-02-27
2015-09-3010.00M shares
10-Q · filed 2016-11-07
7.00M shares
10-Q · filed 2016-11-07
2015-06-306.00M shares
10-Q · filed 2016-08-08
5.00M shares
10-Q · filed 2016-08-08
2015-03-313.00M shares
10-Q · filed 2016-05-09
2014-12-314.00M shares
10-K · filed 2017-02-28
2014-09-305.00M shares
10-Q · filed 2015-11-05
4.00M shares
10-Q · filed 2015-11-05
2014-06-304.00M shares
10-Q · filed 2015-08-06
3.00M shares
10-Q · filed 2015-08-06
2014-03-311.00M shares
10-Q · filed 2015-05-07
2013-12-3125.00M shares
10-K · filed 2016-02-26
2013-09-3023.00M shares
10-Q · filed 2014-11-10
29.00M shares
10-Q · filed 2014-11-10
2013-06-3023.00M shares
10-Q · filed 2014-08-07
32.00M shares
10-Q · filed 2014-08-07
2013-03-3186.00M shares
10-Q · filed 2014-05-08
2012-12-31104.00M shares
10-K · filed 2015-02-27
2012-09-3097.00M shares
10-Q · filed 2013-11-07
111.00M shares
10-Q · filed 2013-11-07
2012-06-30107.00M shares
10-Q · filed 2013-08-07
112.00M shares
10-Q · filed 2013-08-07
2012-03-31117.00M shares
10-Q · filed 2013-05-09
2011-12-31169.00M shares
10-K · filed 2014-02-27
2011-09-30170.00M shares
10-Q · filed 2012-11-09
170.00M shares
10-Q · filed 2012-11-09
2011-06-30138.00M shares
10-Q · filed 2012-08-07
173.00M shares
10-Q · filed 2012-08-07
2011-03-31185.00M shares
10-Q · filed 2012-05-08
2010-12-31174.00M shares
10-K · filed 2013-02-28
2010-09-30173.00M shares
10-Q · filed 2011-11-08
173.20M shares
10-Q · filed 2010-11-08
177.00M shares
10-Q · filed 2011-11-08
177.20M shares
10-Q · filed 2010-11-08
2010-06-30195.00M shares
10-Q · filed 2011-08-08
194.70M shares
10-Q · filed 2010-08-06
179.00M shares
10-Q · filed 2011-08-08
178.70M shares
10-Q · filed 2010-08-06
2010-03-31182.00M shares
10-Q · filed 2011-05-09
2009-12-31228.00M shares
10-K · filed 2012-02-28
2009-09-30223.90M shares
10-Q · filed 2010-11-08
226.80M shares
10-Q · filed 2010-11-08
2009-06-30256.30M shares
10-Q · filed 2010-08-06
228.50M shares
10-Q · filed 2010-08-06
2008-12-31201.00M shares
10-K · filed 2011-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbbVie Inc. (ABBV)United States$468.180B70.37
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
JOHNSON & JOHNSON (JNJ)United States$652.528B29.10
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60